What is Daratumumab?

Category: Prescription Drugs

Most popular types: Darzalex


See also: Daratumumab-bortezomib-dexamethasone Daratumumab-lenalidomide-dexamethasone (DRd)

Daratumumab is a monoclonal antibody used in treatment for individuals with multiple myeloma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 1
Mild 5
None 1

Commonly reported side effects and conditions associated with Daratumumab

Side effect Patients Percentage
Fatigue 3
Chills 1
Flushing 1
Headaches 1
Mucus in stool 1
Nausea 1

Show all 12 reported side effects

Why patients stopped taking Daratumumab

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 1
See 1 patient who's stopped taking Daratumumab


Currently taking Daratumumab

Duration Patients Percentage
2 - 5 years 1

Stopped taking Daratumumab

Duration Patients Percentage
Less than 1 month 1
Adherence Evaluations Percentage
Always 6
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden Evaluations Percentage
Very hard to take 2
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 5
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 3
Not specified 4

What people switch to and from

Patients started taking Daratumumab after stopping:

Treatment Patients Percentage
Carfilzomib (Kyprolis) 4
Ixazomib (Ninlaro) 2
Cyclophosphamide (Cytoxan) 1
Lenalidomide (Revlimid) 1

Patients stopped taking Daratumumab and switched to:

Treatment Patients Percentage
Elotuzumab (Empliciti) 1
Last updated:
There are no evaluations for Daratumumab.